The FGF family: biology, pathophysiology and therapy

被引：1508

作者：

Beenken, Andrew ^{[1
]}

Mohammadi, Moosa ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 03期

关键词：

FIBROBLAST-GROWTH-FACTOR; BILE-ACID SYNTHESIS; DOMINANT HYPOPHOSPHATEMIC RICKETS; ENDOTHELIAL-CELL PROLIFERATION; ACTIVATED-RECEPTOR-GAMMA; CHRONIC KIDNEY-DISEASE; SPINAL-CORD REPAIR; PHASE-II TRIAL; AUTOSOMAL-DOMINANT; MULTIPLE-MYELOMA;

D O I：

10.1038/nrd2792

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.

引用

页码：235 / 253

页数：19

共 278 条

[31] Sunitinib: From rational design to clinical efficacy [J].

Chow, Laura Q. M. ;

Eckhardt, S. Gail .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :884-896

[32]

Colvin JS, 2001, DEVELOPMENT, V128, P2095

[33] Male-to-female sex reversal in mice lacking fibroblast growth factor 9 [J].

Colvin, JS ;

Green, RP ;

Schmahl, J ;

Capel, B ;

Ornitz, DM .

CELL, 2001, 104 (06) :875-889

[34] Naked plasmid DNA encoding fibroblast growth factor type I for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial [J].

Comerota, AJ ;

Throm, RC ;

Miller, KA ;

Henry, T ;

Chronos, N ;

Laird, J ;

Sequeira, R ;

Kent, CK ;

Bacchetta, M ;

Goldman, C ;

Salenius, JP ;

Schmieder, FA ;

Pilsudski, R .

JOURNAL OF VASCULAR SURGERY, 2002, 35 (05) :930-936

[35] Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].

Coskun, Tamer ;

Bina, Holly A. ;

Schneider, Michael A. ;

Dunbar, James D. ;

Hu, Charlie C. ;

Chen, Yanyun ;

Moller, David E. ;

Kharitonenkov, Alexei .

ENDOCRINOLOGY, 2008, 149 (12) :6018-6027

[36] Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders [J].

Cross, Nicholas C. P. ;

Reiter, Andreas .

ACTA HAEMATOLOGICA, 2008, 119 (04) :199-206

[37]

Cuevas P, 1997, Eur J Med Res, V2, P465

[38] HYPOTENSIVE ACTIVITY OF FIBROBLAST GROWTH-FACTOR [J].

CUEVAS, P ;

CARCELLER, F ;

ORTEGA, S ;

ZAZO, M ;

NIETO, I ;

GIMENEZGALLEGO, G .

SCIENCE, 1991, 254 (5035) :1208-1210

[39] Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats [J].

Cuevas, P ;

GarciaCalvo, M ;

Carceller, F ;

Reimers, D ;

Zazo, M ;

Cuevas, B ;

MunozWillery, I ;

MartinezCoso, V ;

Lamas, S ;

GimenezGallego, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11996-12001

[40] Mechanisms underlying differential responses to FGF signaling [J].

Dailey, L ;

Ambrosetti, D ;

Mansukhani, A ;

Basilico, C .

CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (02) :233-247

← 1 2 3 4 5 6 7 8 9 10 →